Tony's Diary Package — page 348

NATIONWIDE COVID-19 METRICS. 7-DAY AVERAGE LINES Apr 1- Sep 15 Daily Tests Daily Cases Currently Hospitalized Daily Deaths Sep 15: 679,505 Sep 15: 35,445 Sep 15: 30,327 Sep 15: 1,031 80,000 60,000 900,000 70,000 2,500 800,000 50,000 60,000 700, . 00,000 2,000 600,000 50,000 40,000 500,000 1,500 40,000 30,000 400,000 30,000 ee 1,000 300,000 20,000 20,000 200,000 10,000 100,000 10,006 Apr Jun Aug 1 Apr Junt Aug 1 Apr Juni Aug 1 Apr Jun 1 Aug1 Source: The COVID Tracking Project 16 September 2020 1. As noted yesterday : Cases and deaths flat primarily due to increases in heartland NOW cases and deaths increasing with >50% deaths in OH, FL, GA, TX, VA and rising deaths/100 cases in many states. 2. New hospital admissions remain high without substantial declines ;: inpatient total declining demonstrating decreasing length of stay --new admissions climbed last week and this week will also be at that elevated level 3. Increasing hospitalizations/100 cases continues and is widening indicating undertesting in areas of community spread 4. 13 states have a greater than 20% decrease in testing week over week which has been accelerating across the USA over the past 3 weeks 5. With hospitalization and deaths rising/100 cases it is a strong indication that community spread maybe increasing in states and we can't see it due to under testing : this is a very dangerous moment and must be corrected 6. Also most states are NOT reporting their Ag tests and this must be corrected immediately 7. CDC needs to call all the attached states with >20% declines in testing to rapidly increase testing and must tell states that Ag reporting is required --recammend changing Ag cases from probable to a actual case -- the sensitivity and specificity of the new Ag tests match the Abbott ID Now which counts as a case §. Attached are the States with a 20% decline in testing over the last 7 days eet ® Did Congressional Hispanic Caucus Institute Leadership Conference with Sanjay Gupta moderating PRESS:Bloomberg News Podcast - David Rubenstein; Business Insider interview; BMJ Podcast; Wall Street Journal podcast interview; Wall Street Journal online event